TW200735869A - Diaryl ureas for treating pulmonary hypertension - Google Patents
Diaryl ureas for treating pulmonary hypertensionInfo
- Publication number
- TW200735869A TW200735869A TW095141430A TW95141430A TW200735869A TW 200735869 A TW200735869 A TW 200735869A TW 095141430 A TW095141430 A TW 095141430A TW 95141430 A TW95141430 A TW 95141430A TW 200735869 A TW200735869 A TW 200735869A
- Authority
- TW
- Taiwan
- Prior art keywords
- pulmonary hypertension
- treating pulmonary
- diaryl ureas
- diaryl
- urea compound
- Prior art date
Links
- -1 Diaryl ureas Chemical class 0.000 title abstract 3
- 208000002815 pulmonary hypertension Diseases 0.000 title abstract 2
- 235000013877 carbamide Nutrition 0.000 title 1
- 239000004202 carbamide Substances 0.000 abstract 2
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960003787 sorafenib Drugs 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05024508 | 2005-11-10 | ||
| EP05027449 | 2005-12-15 | ||
| EP06007775 | 2006-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200735869A true TW200735869A (en) | 2007-10-01 |
Family
ID=37651281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095141430A TW200735869A (en) | 2005-11-10 | 2006-11-09 | Diaryl ureas for treating pulmonary hypertension |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20090176791A1 (zh) |
| EP (1) | EP1948176B1 (zh) |
| JP (1) | JP5075832B2 (zh) |
| KR (1) | KR20080066030A (zh) |
| AR (1) | AR057848A1 (zh) |
| AT (1) | ATE493986T1 (zh) |
| AU (1) | AU2006312713A1 (zh) |
| BR (1) | BRPI0618524A2 (zh) |
| CA (1) | CA2628847A1 (zh) |
| CU (1) | CU23815A3 (zh) |
| DE (1) | DE602006019468D1 (zh) |
| DK (1) | DK1948176T3 (zh) |
| EC (1) | ECSP088429A (zh) |
| IL (1) | IL191010A0 (zh) |
| MY (1) | MY144860A (zh) |
| NO (1) | NO20082497L (zh) |
| NZ (1) | NZ568031A (zh) |
| PL (1) | PL1948176T3 (zh) |
| PT (1) | PT1948176E (zh) |
| SV (1) | SV2009002899A (zh) |
| TW (1) | TW200735869A (zh) |
| UY (1) | UY29902A1 (zh) |
| WO (1) | WO2007054215A1 (zh) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| ATE538794T1 (de) | 1999-01-13 | 2012-01-15 | Bayer Healthcare Llc | Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer |
| MXPA04007832A (es) | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
| UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
| EP1636585B2 (en) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| HRP20060073B1 (hr) | 2003-07-23 | 2014-03-14 | Bayer Healthcare Llc | Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja |
| CN104688697A (zh) | 2005-03-07 | 2015-06-10 | 拜尔健康护理有限责任公司 | 用于治疗癌症的包含ω-羧芳基取代的二苯基脲的药物组合物 |
| WO2007087575A2 (en) * | 2006-01-24 | 2007-08-02 | University Of Chicago | Compositions and methods for treating pulmonary hypertension |
| AR062927A1 (es) * | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
| CA2675980C (en) | 2007-01-19 | 2016-06-21 | Bayer Healthcare Llc | Use of dast for treatment of cancers with acquired resistance to kit inhibitors |
| EP2296641A1 (en) * | 2008-06-25 | 2011-03-23 | Bayer Schering Pharma Aktiengesellschaft | Diaryl urea for treating heart failure |
| AU2011310532B2 (en) | 2010-10-01 | 2016-01-14 | Bayer Intellectual Property Gmbh | Substituted N-(2-arylamino)aryl sulfonamide-containing combinations |
| EP2723717A2 (en) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| MX2013015058A (es) | 2011-06-24 | 2014-01-20 | Amgen Inc | Antagonistas de melastatina 8 de potencial receptor transitorio y su uso en tratamientos. |
| US8586527B2 (en) * | 2011-10-20 | 2013-11-19 | Jaipal Singh | Cerivastatin to treat pulmonary disorders |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| CA2897651C (en) | 2013-01-10 | 2021-09-21 | Pulmokine, Inc. | Non-selective kinase inhibitors |
| CA2926793C (en) | 2013-10-11 | 2022-11-22 | Lawrence S. ZISMAN | Spray-dry formulations for treating pulmonary arterial hypertension |
| US20160317542A1 (en) | 2013-12-09 | 2016-11-03 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
| US11057446B2 (en) | 2015-05-14 | 2021-07-06 | Bright Data Ltd. | System and method for streaming content from multiple servers |
| CN110087653A (zh) | 2016-10-27 | 2019-08-02 | 普尔莫凯恩股份有限公司 | 用于治疗肺高血压的组合疗法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7928239B2 (en) * | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| US20020065296A1 (en) * | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| MXPA04007832A (es) * | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
| EP1636585B2 (en) * | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
-
2006
- 2006-10-30 JP JP2008539298A patent/JP5075832B2/ja not_active Expired - Fee Related
- 2006-10-30 NZ NZ568031A patent/NZ568031A/en not_active IP Right Cessation
- 2006-10-30 EP EP06828882A patent/EP1948176B1/en not_active Not-in-force
- 2006-10-30 PT PT06828882T patent/PT1948176E/pt unknown
- 2006-10-30 MY MYPI20081362A patent/MY144860A/en unknown
- 2006-10-30 CA CA002628847A patent/CA2628847A1/en not_active Abandoned
- 2006-10-30 WO PCT/EP2006/010405 patent/WO2007054215A1/en not_active Ceased
- 2006-10-30 DE DE602006019468T patent/DE602006019468D1/de active Active
- 2006-10-30 DK DK06828882.8T patent/DK1948176T3/da active
- 2006-10-30 AT AT06828882T patent/ATE493986T1/de active
- 2006-10-30 AU AU2006312713A patent/AU2006312713A1/en not_active Abandoned
- 2006-10-30 US US12/084,659 patent/US20090176791A1/en not_active Abandoned
- 2006-10-30 PL PL06828882T patent/PL1948176T3/pl unknown
- 2006-10-30 BR BRPI0618524-0A patent/BRPI0618524A2/pt not_active IP Right Cessation
- 2006-10-30 KR KR1020087011176A patent/KR20080066030A/ko not_active Ceased
- 2006-10-31 AR ARP060104766A patent/AR057848A1/es not_active Application Discontinuation
- 2006-11-07 UY UY29902A patent/UY29902A1/es unknown
- 2006-11-09 TW TW095141430A patent/TW200735869A/zh unknown
-
2008
- 2008-04-27 IL IL191010A patent/IL191010A0/en unknown
- 2008-05-06 EC EC2008008429A patent/ECSP088429A/es unknown
- 2008-05-06 SV SV2008002899A patent/SV2009002899A/es unknown
- 2008-05-08 CU CU20080082A patent/CU23815A3/es not_active IP Right Cessation
- 2008-06-03 NO NO20082497A patent/NO20082497L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL191010A0 (en) | 2009-08-03 |
| KR20080066030A (ko) | 2008-07-15 |
| AR057848A1 (es) | 2007-12-19 |
| PL1948176T3 (pl) | 2011-05-31 |
| JP2009514909A (ja) | 2009-04-09 |
| DE602006019468D1 (de) | 2011-02-17 |
| CA2628847A1 (en) | 2007-05-18 |
| EP1948176A1 (en) | 2008-07-30 |
| SV2009002899A (es) | 2009-04-28 |
| ATE493986T1 (de) | 2011-01-15 |
| PT1948176E (pt) | 2011-03-07 |
| CU20080082A7 (es) | 2011-07-11 |
| MY144860A (en) | 2011-11-30 |
| JP5075832B2 (ja) | 2012-11-21 |
| US20090176791A1 (en) | 2009-07-09 |
| EP1948176B1 (en) | 2011-01-05 |
| DK1948176T3 (da) | 2011-04-18 |
| ECSP088429A (es) | 2008-07-30 |
| NZ568031A (en) | 2011-06-30 |
| WO2007054215A1 (en) | 2007-05-18 |
| CU23815A3 (es) | 2012-06-21 |
| AU2006312713A1 (en) | 2007-05-18 |
| NO20082497L (no) | 2008-06-03 |
| BRPI0618524A2 (pt) | 2011-09-06 |
| UY29902A1 (es) | 2007-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200735869A (en) | Diaryl ureas for treating pulmonary hypertension | |
| BRPI0715893A2 (pt) | composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono | |
| HRP20130891T1 (en) | DGAT inhibitor | |
| CL2007002578A1 (es) | Compuestos derivados de n-(1-ftalazin-1-il-piperidin-4-il)-amidas; composicion farmaceutica; y uso para el tratamiento y prevencion de trastornos de la fertilidad, osteoporosis y cancer. | |
| CL2007003495A1 (es) | Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer. | |
| TW200744588A (en) | Pharmaceutical composition for external use | |
| TW200738234A (en) | Triazole compounds that modulate HSP90 activity | |
| DK1863812T3 (da) | Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler | |
| TW200745124A (en) | Azepinoindole derivatives as pharmaceutical agents | |
| TW200722100A (en) | A therapeutic agent for a β related disorders | |
| CL2007003557A1 (es) | Compuestos derivados de heterociclos de nitrogeno, inhibidores de la actividad sobre b-raf; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
| WO2006125539A3 (en) | Combination therapy comprising diaryl ureas for treating diseases | |
| PT1858877E (pt) | Ureias substituídas 1,3 diarilo, moduladoras da atividade de quinase | |
| WO2007059230A3 (en) | Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors | |
| WO2008073332A3 (en) | Creatine compositions for skin treatment | |
| TW200733961A (en) | Diaryl urea for treating pulmonary hypertension | |
| TW200800967A (en) | Benzimidazole thiophene compounds | |
| WO2007146335A3 (en) | Compounds and compositions for treatment of cancer | |
| WO2007133944A3 (en) | Topical administration of acyclovir | |
| MX2009012525A (es) | Pirazol-pirrolidinas como inhibidores de gamma secretasa. | |
| TW200740429A (en) | Methods and dosage forms for reducing side effects of carbamate compounds | |
| MX2010014441A (es) | Diaril ureas para tratar la insuficiencia cardiaca. | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| TW200800993A (en) | Organic compounds | |
| WO2008070354A3 (en) | 5- and 6- substituted benzimidazole thiophene compounds |